CIK 0001088856
- Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770487658
- Phone
- +1 650-688-8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale See Remarks sold 625 shares at $25.28 ($15,800)
- 4 Open-market sale Chief Business Officer sold 5,000 shares at $26.03 ($130,150)
- 4 Open-market sale Chief Business Officer sold 23,401 shares at an average $26.27 ($614,788)
- 4 Open-market sale See Remarks sold 25,000 shares at $25.57 ($639,250)
- 4 Open-market sale See Remarks sold 25,000 shares at $25.64 ($641,000)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 29,997 shares (to pay taxes)
- 4 Open-market sale Chief Business Officer sold 50,000 shares at $26.06 ($1,303,000)
- 4 Grant or award Chief Business Officer acquired 2,020 shares (grant or award)
- 4 Open-market sale See Remarks sold 25,000 shares at $25.84 ($646,000)
- 4 Grant or award Chief Financial Officer acquired 1,586 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 1,844 shares (grant or award)
- 4 Shares withheld for taxes Chief Business Officer gave up 93,922 shares (to pay taxes)
- 4 Option exercise See Remarks acquired 15,000 shares (option exercise)
- 4 Option exercise See Remarks acquired 24,800 shares (option exercise)
- 4 Open-market sale See Remarks sold 200 shares at $28.70 ($5,740)
- 4 Open-market sale Director sold 15,385 shares at $28.32 ($435,703)
- 4 Open-market sale See Remarks sold 25,000 shares at $27.37 ($684,250)
- 4 Open-market sale Chief Executive Officer sold 335,019 shares at an average $26.26 ($8,798,952)
Page 18 of 60 · 1,197 filings